COVID-19 Vaccine Effectiveness in Oncology Patients

Oncology patients are at greater risk of morbidity and mortality from coronavirus disease 2019 (COVID-19) infection than the general population. Patients with malignancies were prioritized in vaccine distribution to confer protection to a vulnerable population. However, immunocompromised patients we...

Descripción completa

Detalles Bibliográficos
Autor principal: LA Costa, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Practice Matters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214963/
https://www.ncbi.nlm.nih.gov/pubmed/35755900
http://dx.doi.org/10.6004/jadpro.2022.13.4.6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214963/
https://www.ncbi.nlm.nih.gov/pubmed/35755900
http://dx.doi.org/10.6004/jadpro.2022.13.4.6

Ejemplares similares